ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1921–1932 of 2020 project topics
Hereditary Stomatocytosis and Dehydration
Characterizing PIEZO1 gain-of-function variants causing dehydrated hereditary stomatocytosis for molecular diagnosis and splenectomy risk counseling.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Congenital Dyserythropoietic Anemia Gene Testing
Testing SEC23B, KLF1, C15ORF41, and CDAN1 genes for CDA type classification for molecular diagnosis in patients with refractory anemia.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Hereditary Aceruloplasminemia CP Gene Testing
Characterizing ceruloplasmin gene variants causing aceruloplasminemia for diagnosing iron accumulation disorder and chelation therapy guidance.
Genetic Basis of Rare Hematological Conditions Click to view more details →
May-Hegglin and MYH9-Related Disorders
Identifying MYH9 variants causing May-Hegglin anomaly and related giant platelet disorders for molecular diagnosis and renal surveillance.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Bernard-Soulier Syndrome GP1B Gene Diagnostic SaaS Platform
A cloud-based diagnostic platform that sequences and analyzes GP1B gene mutations to identify Bernard-Soulier Syndrome with automated clinical reporting and variant interpretation. This SaaS solution enables laboratories to offer rapid turnaround testing while generating recurring subscription revenue and per-test fees from hematology clinics.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Gray Platelet Syndrome NBEAL2 Mutation Detection Commercial Kit
A ready-to-use molecular diagnostic kit that detects pathogenic NBEAL2 variants associated with Gray Platelet Syndrome through targeted sequencing and genotyping. This product creates a sustainable revenue stream through kit sales to hospital laboratories and direct-to-consumer genetic testing companies worldwide.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Thrombocytopenia Absent Radius TPM4 Testing Service Network
A specialized clinical laboratory service network offering TPM4 and RBM8A gene testing for Thrombocytopenia Absent Radius diagnosis with telemedicine consultation integration. This service model generates revenue through test fees, consultation charges, and referral partnerships with pediatric orthopedic and hematology practices.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Wiskott-Aldrich Syndrome WAS Gene Carrier Screening Mobile App
An AI-powered mobile application that predicts WAS gene carrier status and risk stratification using genomic data analysis and clinical phenotyping algorithms. The app monetizes through subscription licensing to genetic counseling centers, prenatal screening programs, and healthcare insurance companies seeking cost-effective risk assessment tools.
Genetic Basis of Rare Hematological Conditions Click to view more details →
X-Linked Thrombocytopenia GATA1 Variant Analysis Enterprise Software
Enterprise software that automates GATA1 mutation analysis, phenotype correlation, and prognosis prediction for X-linked thrombocytopenia and related disorders. This platform generates B2B revenue through licensing fees to large diagnostic laboratories and hospital health systems requiring high-throughput variant interpretation.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Familial Platelet Disorder RUNX1 Gene Commercial Sequencing Service
A specialized whole-exome and targeted deep-sequencing service identifying RUNX1 germline mutations in families with platelet dysfunction and inherited bleeding disorders. This service generates recurring revenue through high-margin test fees, multi-family screening contracts, and partnerships with hematology research institutions.
Genetic Basis of Rare Hematological Conditions Click to view more details →
Human Genetic Evidence for Drug Target Validation
Using Mendelian randomization and genetic association studies to validate drug targets using human genetic evidence before clinical development.
Translational Genetics and Therapeutic Development Click to view more details →
Genetic Patient Stratification for Clinical Trials
Developing genetic stratification strategies for clinical trials based on disease-causing mutation class for improving treatment effect detection.
Translational Genetics and Therapeutic Development Click to view more details →